Table of Contents Author Guidelines Submit a Manuscript
Journal of Healthcare Engineering
Volume 4, Issue 1, Pages 67-86
http://dx.doi.org/10.1260/2040-2295.4.1.67
Research Article

Perspectives of Nanotechnology in Minimally Invasive Therapy of Breast Cancer

Yamin Yang and Hongjun Wang

Chemistry, Chemical Biology and Biomedical Engineering, Stevens Institute of Technology, Hoboken, NJ 07030, USA

Received 1 September 2012; Accepted 1 November 2012

Copyright © 2013 Hindawi Publishing Corporation. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. What are the key statistics about breast cancer?, http://www.cancer.org/cancer/breastcancer/detailedguide/breast-cancer-key-statistics, Accessed December 05, 2012.
  2. H. M. Heneghan, R. S. Prichard, A. Devaney et al., “Evolution of breast cancer management in Ireland: a decade of change,” BMC surgery, vol. 9:15, 2009. View at Google Scholar
  3. P. D. Loprinzi and B. J. Cardinal, “Effects of physical activity on common side effects of breast cancer treatment,” Breast cancer, vol. 19, pp. 4–10, 2012. View at Google Scholar
  4. M. Noguchi, “Minimally invasive surgery for small breast cancer,” Journal of surgical oncology, vol. 84, pp. 94–101, 2003. View at Google Scholar
  5. S. E. V. A. Singletary, “Minimally invasive techniques in breast,” Seminars in Surgical Oncology, vol. 20, no. 3, pp. 246–250, 2001. View at Google Scholar
  6. W. K. Hung, M. Ying, C. M. Chan, H. S. Lam, and K. L. Mak, “Minimally invasive technology in the management of breast disease,” Breast cancer, vol. 16, pp. 23–29, 2009. View at Google Scholar
  7. I. Brigger, C. Dubernet, and P. Couvreur, “Nanoparticles in cancer therapy and diagnosis,” Advanced drug delivery reviews, vol. 54, pp. 631–651, 2012. View at Google Scholar
  8. Y.--E. Choi, J.-W. Kwak, and J. W. Park, “Nanotechnology for early cancer detection,” Sensors, vol. 10, pp. 428–455, 2010. View at Google Scholar
  9. J. Conde, G. Doria, and P. Baptista, “Noble metal nanoparticles applications in cancer,” Journal of drug delivery, 2012, 751075. View at Google Scholar
  10. L. Brannon-Peppas and J. O. Blanchette, “Nanoparticle and targeted systems for cancer therapy,” Advanced drug delivery reviews, vol. 56, pp. 1649–1659, 2004. View at Google Scholar
  11. O. M. Koo, I. Rubinstein, and H. Onyuksel, “Role of nanotechnology in targeted drug delivery and imaging: a concise review,” NanoMedicine: nanotechnology, biology, and medicine, vol. 1, pp. 193–212, 2005. View at Google Scholar
  12. R. Sinha, G. J. Kim, S. Nie, and D. M. Shin, “Nanotechnology in cancer therapeutics: bioconjugated nanoparticles for drug delivery,” Molecular cancer therapeutics, vol. 5, pp. 1909–1917, 2006. View at Google Scholar
  13. K. Kim, J. H. Kim, H. Park et al., “Tumor-homing multifunctional nanoparticles for cancer theragnosis: Simultaneous diagnosis, drug delivery, and therapeutic monitoring,” Journal of controlled release, vol. 146, pp. 219–227, 2010. View at Google Scholar
  14. M. Wang and M. Thanou, “Targeting nanoparticles to cancer,” Pharmacological research: the official journal of the Italian Pharmacological Society, vol. 62, pp. 90–99, 2010. View at Google Scholar
  15. M. K. Yu, J. Park, Y. Y. Jeong, W. K. Moon, and S. Jon, “Integrin-targeting thermally cross-linked superparamagnetic iron oxide nanoparticles for combined cancer imaging and drug delivery,” Nanotechnology, vol. 21:415102, 2010. View at Google Scholar
  16. V. P. Torchilin, “Polymer-coated long-circulating microparticulate pharmaceuticals,” Journal of microencapsulation, vol. 15, pp. 1–19, 1998. View at Google Scholar
  17. A. Moore, E. Marecos, A. Bogdanov, and R. Weissleder, “Tumoral distribution of iron oxide nanoparticles in a rodent model 1,” Radiology, vol. 214, 2000. View at Google Scholar
  18. S. M. Moghimi, a. C. Hunter, and J. C. Murray, “Long-circulating and target-specific nanoparticles: theory to practice,” Pharmacological reviews, vol. 53, pp. 283–318, 2001. View at Google Scholar
  19. P. Senthil Kumar, I. Pastoriza-Santos, B. Rodríguez-González, F. Javier García de Abajo, and L. M. Liz-Marzán, “High-yield synthesis and optical response of gold nanostars,” Nanotechnology, vol. 19:015606, 2008. View at Google Scholar
  20. L. Principe, S. D'Arezzo, A. Capone, N. Petrosillo, and P. Visca, “In vitro activity of tigecycline in combination with various antimicrobials against multidrug resistant Acinetobacter baumannii,” Annals of clinical microbiology and antimicrobials, vol. 8:18, 2009. View at Google Scholar
  21. T. L. Doane and C. Burda, “The unique role of nanoparticles in nanomedicine: imaging, drug delivery and therapy,” Chemical Society reviews, vol. 41, pp. 2885–2911, 2012. View at Google Scholar
  22. C. L. Waite and C. M. Roth, “Nanoscale drug delivery systems for enhanced drug penetration into solid tumors: current progress and opportunities,” Critical reviews in biomedical engineering, vol. 40, pp. 21–41, 2012. View at Google Scholar
  23. R. Ranganathan, S. Madanmohan, A. Kesavan et al., “Nanomedicine: towards development of patient-friendly drug-delivery systems for oncological applications,” International journal of nanomedicine, vol. 7, pp. 1043–1060, 2012. View at Google Scholar
  24. C. Heneweer, S. E. M. Gendy, and O. Peñate-Medina, “Liposomes and inorganic nanoparticles for drug delivery and cancer imaging,” .Therapeutic delivery, vol. 3, pp. 645–656, 2012. View at Google Scholar
  25. P. Kumar, A. Gulbake, and S. K. Jain, “Liposomes a vesicular nanocarrier: potential advancements in cancer chemotherapy,” Critical reviews in therapeutic drug carrier Systems, vol. 29, pp. 355–419, 2012. View at Google Scholar
  26. Y. Namiki, T. Fuchigami, N. Tada et al., “Nanomedicine for cancer: lipid-based nanostructures for drug delivery and monitoring,” Accounts of chemical research, vol. 44, pp. 1080–1093, 2011. View at Google Scholar
  27. C.-M. J. Hu and L. Zhang, “Nanoparticle-based combination therapy toward overcoming drug resistance in cancer,” Biochemical pharmacology, vol. 83, pp. 1104–1111, 2012. View at Google Scholar
  28. L. M. Kaminskas, V. M. McLeod, C. J. H. Porter, and B. J. Boyd, “Association of chemotherapeutic drugs with dendrimer nanocarriers: an assessment of the merits of covalent conjugation compared to noncovalent encapsulation,” Molecular pharmaceutics, vol. 9, pp. 355–373, 2012. View at Google Scholar
  29. M. Wankhede, A. Bouras, M. Kaluzova, and C. G. Hadjipanayis, “Magnetic nanoparticles: an emerging technology for malignant brain tumor imaging and therapy,” Expert review of clinical pharmacology, vol. 5, pp. 173–186, 2012. View at Google Scholar
  30. L. Tong, M. Zhao, S. Zhu, and J. Chen, “Synthesis and application of superparamagnetic iron oxide nanoparticles in targeted therapy and imaging of cancer,” Frontiers of medicine, vol. 5, pp. 379–387, 2011. View at Google Scholar
  31. L. Dykman and N. Khlebtsov, “Gold nanoparticles in biomedical applications: recent advances and perspectives,” Chemical Society reviews, vol. 41, pp. 2256–2282, 2012. View at Google Scholar
  32. P. Cherukuri and S. A. Curley, “Use of nanoparticles for targeted, noninvasive thermal destruction of malignant cells,” Methods in molecular biology, vol. 624, pp. 359–373, 2010. View at Google Scholar
  33. S. Abbasi, A. Paul, W. Shao, and S. Prakash, “Cationic albumin nanoparticles for enhanced drug delivery to treat breast cancer: preparation and in vitro assessment,” Journal of drug delivery, 2012, 686108. View at Google Scholar
  34. Lee S.-M., T. V. O'Halloran, and S. T. Nguyen, “Polymer-caged nanobins for synergistic cisplatin-doxorubicin combination chemotherapy,” Journal of the American Chemical Society, vol. 132, pp. 17130–17138, 2010. View at Google Scholar
  35. F. Danhier, N. Lecouturier, B. Vroman et al., “Paclitaxel-loaded PEGylated PLGA-based nanoparticles: in vitro and in vivo evaluation,” Journal of controlled release: official journal of the Controlled Release Society, vol. 133, pp. 11–17, 2009. View at Google Scholar
  36. C. Yang, H. Z. Liu, Z. X. Fu, and W. D. Lu :, “Oxaliplatin long-circulating liposomes improved therapeutic index of colorectal carcinoma,” BMC biotechnology, vol. 11:21, 2011. View at Google Scholar
  37. P. Agrawal, G. J. Strijkers, and K. Nicolay, “Chitosan-based systems for molecular imaging,” Advanced drug delivery reviews, vol. 62, pp. 42–58, 2010. View at Google Scholar
  38. R. M. Taylor and L. O. Sillerud, “Paclitaxel-loaded iron platinum stealth immunomicelles are potent MRI imaging agents that prevent prostate cancer growth in a PSMA-dependent manner,” International journal of nanomedicine, vol. 7, pp. 4341–4352, 2012. View at Google Scholar
  39. L. Xu, K. F. Pirollo, W. H. Tang, A. Rait, and E. H. Chang, “Transferrin-liposome-mediated systemic p53 gene therapy in combination with radiation results in regression of human head and neck cancer xenografts,” Human gene therapy, vol. 10, pp. 2941–2952, 1999. View at Google Scholar
  40. Y. Wu, W. Wang, Y. Chen et al., “The investigation of polymer-siRNA nanoparticle for gene therapy of gastric cancer in vitro,” International journal of nanomedicine, vol. 5, pp. 129–136, 2010. View at Google Scholar
  41. T. R. Daniels, E. Bernabeu, J. A. Rodríguez et al., “The transferrin receptor and the targeted delivery of therapeutic agents against cancer,” Biochimica et biophysica acta, vol. 1820, pp. 291–317, 2012. View at Google Scholar
  42. R. S. T. Aydin, “Herceptin-decorated salinomycin-loaded nanoparticles for breast tumor targeting,” Journal of biomedical materials research. Part A, 2012. View at Google Scholar
  43. Y. Mi, X. Liu, J. Zhao, J. Ding, and S.-S. Feng, “Multimodality treatment of cancer with herceptin conjugated, thermomagnetic iron oxides and docetaxel loaded nanoparticles of biodegradable polymers,” Biomaterials, vol. 33, pp. 7519–7529, 2012. View at Google Scholar
  44. P. Zhao, H. Wang, M. Yu et al., “Paclitaxel loaded folic acid targeted nanoparticles of mixed lipid-shell and polymer-core: in vitro and in vivo evaluation,” European journal of pharmaceutics and biopharmaceutics, vol. 81, pp. 248–256, 2012. View at Google Scholar
  45. B. D. Fornage and B. S. Edeiken, “Percutaneous ablation of breast tumors,” Tumor ablation, vol. 5, pp. 428–439, 2005. View at Google Scholar
  46. M. Salagierski and M. S. Salagierski, “Radiofrequency Ablation: A Minimally Invasive Approach in Kidney Tumor Management,” Cancers, vol. 2, pp. 1895–1900, 2010. View at Google Scholar
  47. R. W. Y. Habash, R. Bansal, D. Krewski, and T. Hafi, “Thermal therapy, Part III: ablation,” vol. 35, pp. 37–121, 2007. View at Google Scholar
  48. J. Cardinal, J. R. Klune, E. Chory et al., “Non-invasive radiofrequency ablation of cancer targeted by gold nanoparticles,” Surgery, vol. 144, pp. 125–132, 2008. View at Google Scholar
  49. C. J. Gannon, C. R. Patra, R. Bhattacharya, P. Mukherjee, and S. Curley, “Intracellular gold nanoparticles enhance non-invasive radiofrequency thermal destruction of human gastrointestinal cancer cells,” Journal of nanobiotechnology, vol. 6:2, 2008. View at Google Scholar
  50. V. H. B. Ho, M. J. Smith, and N. K. H. Slater, “Effect of magnetite nanoparticle agglomerates on the destruction of tumor spheroids using high intensity focused ultrasound.,” Ultrasound in medicine & biology, vol. 37, pp. 169–175, 2011. View at Google Scholar
  51. Y. Sun, Y. Zheng, H. Ran et al., “Superparamagnetic PLGA-iron oxide microcapsules for dual-modality US/MR imaging and high intensity focused US breast cancer ablation,” Biomaterials, vol. 33, pp. 5854–5864, 2012. View at Google Scholar
  52. J.-F. Yan and J. Liu, “Nanocryosurgery and its mechanisms for enhancing freezing efficiency of tumor tissues,” NanoMedicine: nanotechnology, biology, and medicine, vol. 4, pp. 79–87, 2008. View at Google Scholar
  53. R. Goel, D. Swanlund, J. Coad, G. F. Paciotti, and J. C. Bischof, “TNF-alpha-based accentuation in cryoinjury—dose, delivery, and response,” Molecular cancer therapeutics, vol. 6, pp. 2039–2047, 2007. View at Google Scholar
  54. Y. N. Konan, M. Berton, R. Gurny, and E. Allémann, “Enhanced photodynamic activity of meso-tetra(4-hydroxyphenyl)porphyrin by incorporation into sub-200 nm nanoparticles,” European journal of pharmaceutical sciences, vol. 18, pp. 241–249, 2003. View at Google Scholar
  55. E. Ricci-Júnior and J. M. Marchetti, “Zinc(II) phthalocyanine loaded PLGA nanoparticles for photodynamic therapy use,” International journal of pharmaceutics, vol. 310, pp. 187–195, 2006. View at Google Scholar
  56. I. Roy, T. Y. Ohulchanskyy, H. E. Pudavar et al., “Ceramic-based nanoparticles entrapping water-insoluble photosensitizing anticancer drugs: a novel drug-carrier system for photodynamic therapy,” Journal of the American Chemical Society, vol. 125, pp. 7860–7865, 2003. View at Google Scholar
  57. M. E. Wieder, D. C. Hone, M. J. Cook, M. M. Handsley, J. Gavrilovic, and D. Russell, “Intracellular photodynamic therapy with photosensitizer-nanoparticle conjugates: cancer therapy using a “Trojan horse”,” Photochemical & photobiological sciences, vol. 5, pp. 727–734, 2006. View at Google Scholar
  58. M. Kyaw, K. Oo, X. Yang, H. Du, and H. Wang, “5-aminolevulinic acid-conjugated gold nanoparticles for photodynamic therapy of cancer,” Nanomedicine, vol. 3, no. 6, pp. 777–786, 2008. View at Google Scholar
  59. M. K. Khaing Oo, Y. Yang, Y. Hu, M. Gomez, H. Du, and H. Wang, “Gold nanoparticle-enhanced and size-dependent generation of reactive oxygen species from protoporphyrin IX,” ACS nano, vol. 6, pp. 1939–1947, 2012. View at Google Scholar
  60. I. H. El-Sayed, X. Huang, and M. El-Sayed, “Selective laser photo-thermal therapy of epithelial carcinoma using anti-EGFR antibody conjugated gold nanoparticles,” Cancer letters, vol. 239, pp. 129–135, 2006. View at Google Scholar
  61. X. Huang, P. K. Jain, I. H. El-Sayed, and M. El-Sayed, “Plasmonic photothermal therapy (PPTT) using gold nanoparticles,” Lasers in medical science, vol. 23, pp. 217–28, 2008. View at Google Scholar
  62. L. B. Carpin, L. R. Bickford, G. Agollah et al., “Immunoconjugated gold nanoshell-mediated photothermal ablation of trastuzumab-resistant breast cancer cells,” Breast cancer research and treatment, vol. 125, pp. 27–34, 2011. View at Google Scholar
  63. G. von Maltzahn, J.-H. Park, A. Agrawal et al., “Computationally guided photothermal tumor therapy using long-circulating gold nanorod antennas,” Cancer research, vol. 69, pp. 3892–3900, 2009. View at Google Scholar
  64. F. Zhou, D. Xing, Z. Ou, B. Wu, D. E. Resasco, and W. R. Chen, “Cancer photothermal therapy in the near-infrared region by using single-walled carbon nanotubes,” Journal of biomedical optics, vol. 14: 021009, 2009. View at Google Scholar
  65. G. Vlastos and H. M. Verkooijen, “Minimally invasive approaches for diagnosis and treatment of early-stage breast cancer,” The oncologist, vol. 12, pp. 1–10, 2007. View at Google Scholar
  66. A. N. Mirza, B. D. Fornage, N. Sneige et al., “Radiofrequency ablation of solid tumors,” Cancer journal, vol. 7, pp. 95–102, 2001. View at Google Scholar
  67. F. Izzo, R. Thomas, P. Delrio et al., “Radiofrequency ablation in patients with primary breast carcinoma: a pilot study in 26 patients,” Cancer, vol. 92, pp. 2036–44, 2001. View at Google Scholar
  68. Z.-Z. J. Lim, J.-E. J. Li , C.-T. Ng , L.-Y. L. Yung, and B.-H. Bay, “Gold nanoparticles in cancer therapy,” Acta pharmacologica Sinica, vol. 32, pp. 983–990, 2011. View at Google Scholar
  69. S. Jain, D. G. Hirst, and J. M. O'Sullivan, “Gold nanoparticles as novel agents for cancer therapy,” The British journal of radiology, vol. 85, pp. 101–113, 2012. View at Google Scholar
  70. X. Huang, P. K. Jain, I. H. El-Sayed, and M. A. El-Sayed, “Gold nanoparticles: interesting optical properties and recent applications in cancer diagnostics and therapy,” Nanomedicine, vol. 2, pp. 681–693, 2007. View at Google Scholar
  71. R. A. Rippel and A. M. Seifalian, “Gold revolution-gold nanoparticles for modern medicine and surgery,” Journal of nanoscience and nanotechnology, vol. 11, pp. 3740–3748, 2011. View at Google Scholar
  72. S. Lee, H. Chon, M. Lee et al., “Surface-enhanced Raman scattering imaging of HER2 cancer markers overexpressed in single MCF7 cells using antibody conjugated hollow gold nanospheres,” Biosensors & bioelectronics, vol. 24, pp. 2260–2263, 2009. View at Google Scholar
  73. N. Chattopadhyay, Z. Cai, J. Pignol et al., “Design and characterization of her-2-targeted gold nanoparticles for enhanced X-radiation treatment of locally advanced breast cancer,” Mol. Pharmaceutics, vol. 7, no. 6, pp. 2194–2206, 2010. View at Google Scholar
  74. L. Chen, D. Bouley, E. Yuh, H. D'Arceuil, and K. Butts, “Study of focused ultrasound tissue damage using MRI and histology,” Journal of magnetic resonance imaging, vol. 10, pp. 146–153, 1999. View at Google Scholar
  75. McDannold, K. Hynynen, D. Wolf, G. Wolf, and F. Jolesz, “MRI evaluation of thermal ablation of tumors with focused ultrasound,” Journal of magnetic resonance imaging, vol. 8, pp. 91–100, 1998. View at Google Scholar
  76. H. E. Cline, K. Hynynen, R. D. Watkins et al., “Focused US system for MR imaging-guided tumor ablation,” Radiology, vol. 194, pp. 731–737, 1995. View at Google Scholar
  77. D. Gianfelice, A. Khiat, M. Amara, and A. Belblidia, “Radiology MR imaging-guided focused us ablation of breast cancer: histopathologic assessment of effectiveness- initial,” Radiology, vol. 227, no. 3, pp. 849–855, 2002. View at Google Scholar
  78. J. E. Kennedy, “High-intensity focused ultrasound in the treatment of solid tumours. Nature reviews,” Cancer, vol. 5, pp. 321–327, 2005. View at Google Scholar
  79. Y.-Y. Li, W.-H. Sha, Y.-J. Zhou, and Y.-Q. Nie, “Short and long term efficacy of high intensity focused ultrasound therapy for advanced hepatocellular carcinoma,” Journal of gastroenterology and hepatology, vol. 22, pp. 2148–2154, 2007. View at Google Scholar
  80. S.-Y. Choi, Y.-S. Kim, Y.-J. Seo, J. Yang, and K.-S. Choi, “Gas-filled phospholipid nanoparticles conjugated with gadolinium play a role as a potential theragnostics for MR-guided HIFU ablation,” PloS One, vol. 7:e34333, 2012. View at Google Scholar
  81. D. Theodorescu, “Cancer cryotherapy: evolution and biology,” Rev Urol, vol. 6, Suppl 4, pp. S9–S19, 2004. View at Google Scholar
  82. R. Goel, K. Anderson, J. Slaton et al., “Adjuvant approaches to enhance cryosurgery,” Journal of biomechanical engineering, vol. 131:074003, 2009. View at Google Scholar
  83. M. S. Sabel, C. S. Kaufman, P. Whitworth et al., “Cryoablation of early-stage breast cancer: work-in-progress report of a multi-institutional trial,” Annals of surgical oncology, vol. 11, pp. 542–549, 2004. View at Google Scholar
  84. J. Liu and Z.-S. Deng, “Nano-cryosurgery: advances and challenges,” Journal of Nanoscience and Nanotechnology, vol. 9, pp. 4521–4542, 2009. View at Google Scholar
  85. D. C. Shackley, C. Whitehurst, J. V. Moore, and C. Betts, “Photodynamic therapy,” Journal of the royal society of medicine, vol. 92, no. 11, pp. 562–565, 1999. View at Google Scholar
  86. V. Santosa and L. Limantara, “Review photodynamic therapy: new light in medicine worlD,” Indo. J. Chem, vol. 8, pp. 279–291, 2008. View at Google Scholar
  87. J.-H. Yoon, H.-E. Yoon, O. Kim, S. K. Kim, S.-G. Ahn, and K. W. Kang, “The enhanced anti-cancer effect of hexenyl ester of 5-aminolaevulinic acid photodynamic therapy in adriamycin-resistant compared to non-resistant breast cancer cells,” Lasers in surgery and medicine, vol. 44, pp. 76–86, 2012. View at Google Scholar
  88. A.-R. Montazerabadi, A. Sazgarnia, M. H. Bahreyni-Toosi, A. Ahmadi, A. Shakeri-Zadeh, and A. Aledavood, “Mitoxantrone as a prospective photosensitizer for photodynamic therapy of breast cancer,” Photodiagnosis and photodynamic therapy, vol. 9, pp. 46–51, 2012. View at Google Scholar
  89. T.-G. Ahn, B.-R. Lee, E.-Y. Choi, D. W. Kim, and S.-J. Han, “Photodynamic therapy for breast cancer in a BALB/c mouse model,” Journal of gynecologic oncology, vol. 23, pp. 115–119, 2012. View at Google Scholar
  90. D. K. Chatterjee, L. S. Fong, and Y. Zhang, “Nanoparticles in photodynamic therapy: an emerging paradigm,” Advanced drug delivery reviews, vol. 60, pp. 1627–1637, 2008. View at Google Scholar
  91. J. Qian, D. Wang, F. Cai, Q. Zhan, Y. Wang, and S. He, “Photosensitizer encapsulated organically modified silica nanoparticles for direct two-photon photodynamic therapy and in vivo functional imaging,” Biomaterials, vol. 33, pp. 4851–4860, 2012. View at Google Scholar
  92. X. Jia and L. Jia, “Nanoparticles improve biological functions of phthalocyanine photosensitizers used for photodynamic therapy,” Current drug metabolism, 2012. View at Google Scholar
  93. S. Battah, S. Balaratnam, A. Casas et al., “.Macromolecular delivery of 5-aminolaevulinic acid for photodynamic therapy using dendrimer conjugates,” Molecular cancer therapeutics, vol. 6, pp. 876–85, 2007. View at Google Scholar
  94. P. Huang, J. Lin, D. Yang, C. Zhang, Z. Li, and D. Cui, “Photosensitizer-loaded dendrimer-modified multi-walled carbon nanotubes for photodynamic therapy,” Journal of controlled release, vol. 152, Suppl, pp. e33–4, 2011. View at Google Scholar
  95. T. Stuchinskaya, M. Moreno, M. J. Cook, D. R. Edwards, and D. A. Russell, “Targeted photodynamic therapy of breast cancer cells using antibody-phthalocyanine-gold nanoparticle conjugates,” Photochemical & photobiological sciences, vol. 10, pp. 822–831, 2011. View at Google Scholar
  96. N. Kameyama, S. Matsuda, O. Itano et al., “Photodynamic therapy using an anti-EGF receptor antibody complexed with verteporfin nanoparticles: a proof of concept study,” Cancer biotherapy & radiopharmaceuticals, vol. 26, pp. 697–704, 2011. View at Google Scholar
  97. B. Jang, J. Park, C. Tung, I. Kim, and Y. Choi, “Gold nanorod-photosensitizer complex for near-infrared fluorescence imaging and photodynamic/photothermal therapy in vivo,” ACS Nano, vol. 5, no. 2, pp. 1086–1094, 2011. View at Google Scholar
  98. B. Jang and Y. Choi, “Photosensitizer-conjugated gold nanorods for enzyme-activatable fluorescence imaging and photodynamic therapy,” Theranostics, vol. 2, pp. 190–197, 2012. View at Google Scholar
  99. W.--S. Kuo , C.-N. Chang, Y.-T. Chang et al., “Gold nanorods in photodynamic therapy, as hyperthermia agents, and in near-infrared optical imaging,” Angewandte Chemie, vol. 49, pp. 2711–2715, 2010. View at Google Scholar
  100. J. C. Y. Kah, R. C. Y. Wan, K. Y. Wong, S. Mhaisalkar, C. J. R. Sheppard, and M. Olivo, “Combinatorial treatment of photothermal therapy using gold nanoshells with conventional photodynamic therapy to improve treatment efficacy: an in vitro study,” Lasers in surgery and medicine, vol. 40, pp. 584–589, 2008. View at Google Scholar
  101. E. S. Day, P. Thompson, L. Zhang et al., “Nanoshell-mediated photothermal therapy improves survival in a murine glioma model,” Journal of neuro-oncology, vol. 104, pp. 55–63, 2011. View at Google Scholar
  102. J. K. Young, E. R. Figueroa, and R. Drezek, “Tunable nanostructures as photothermal theranostic agents,” Annals of biomedical engineering, vol. 40, pp. 438–459, 2012. View at Google Scholar
  103. R. J. Bernardi, A. R. Lowery, P. A. Thompson, S. M. Blaney, and J. L. West, “Immunonanoshells for targeted photothermal ablation in medulloblastoma and glioma: an in vitro evaluation using human cell lines,” Journal of neuro-oncology, vol. 86, pp. 165–172, 2008. View at Google Scholar
  104. A. M. Gobin, M. H. Lee, N. J. Halas, W. D. James, R. A. Drezek, and J. L. West, “Near-infrared resonant nanoshells for combined optical imaging and photothermal cancer therapy,” Nano letters, vol. 7, pp. 1929–1934, 2007. View at Google Scholar
  105. A. M. Gobin, E. M. Watkins, E. Quevedo, V. L. Colvin, and L. West, “Near infrared resonant gold/gold sulfide nanoparticles as a photothermal cancer therapeutic agent,” Small, no. 6, pp. 745–752, 2011. View at Google Scholar
  106. K. C. Black, J. Yi, J. G. Rivera, D. C. Zelasko-Leon, and P. B. Messersmith, “Polydopamine-enabled surface functionalization of gold nanorods for cancer cell-targeted imaging and photothermal therapy,” Nanomedicine, 2012. View at Google Scholar
  107. C. Hong, “Photothermal therapy using TiO2 nanotubes in combination with near-infrared laser,” Journal of Cancer Therapy, vol. 01, pp. 52–58, 2010. View at Google Scholar
  108. X. Wang, C. Wang, L. Cheng, S.-T. Lee, and Z. Liu, “Noble metal coated single-walled carbon nanotubes for applications in surface enhanced Raman scattering imaging and photothermal therapy,” Journal of the American Chemical Society, vol. 134, pp. 7414–7422, 2012. View at Google Scholar
  109. F. Liang and B. Chen, “A review on biomedical applications of single-walled carbon nanotubes,” Current medicinal chemistry, vol. 17, pp. 10–24, 2010. View at Google Scholar
  110. A. V. Liopo, M. P. Stewart, J. Hudson, J. M. Tour, and T. C. Pappas, “Biocompatibility of native and functionalized single-walled carbon nanotubes for neuronal interface,” Journal of nanoscience and nanotechnology, vol. 6, pp. 1365–1374, 2006. View at Google Scholar
  111. G. von Maltzahn, J.-H. Park, A. Agrawal et al., “Computationally guided photothermal tumor therapy using long-circulating gold nanorod antennas,” Cancer research, vol. 69, pp. 3892–3900, 2009. View at Google Scholar
  112. W. Cai, “Applications of gold nanoparticles in cancer nanotechnology,” Nanotechnology, Science and Applications, vol. 1, pp. 17–32, 2008. View at Google Scholar
  113. A. Albanese, P. S. Tang, and W. C. W. Chan, “The effect of nanoparticle size, shape, and surface chemistry on biological systems,” Annual review of biomedical engineering, vol. 14, pp. 1–16, 2012. View at Google Scholar
  114. M. M. Shenoi, N. B. Shah, R. J. Griffin, G. M. Vercellotti, and J. C. Bischof, “Nanoparticle pre-conditioning for enhanced thermal therapies in cancer,” Nanomedicine, vol. 6, pp. 545–563, 2011. View at Google Scholar
  115. C. Buzea, I. I. Pacheco, and K. Robbie, “Nanomaterials and nanoparticles: sources and toxicity,” Biointerphases, vol. 2, pp. MR17–71, 2007. View at Google Scholar
  116. R. Shukla, V. Bansal, M. Chaudhary, A. Basu, R. R. Bhonde, and M. Sastry, “Biocompatibility of gold nanoparticles and their endocytotic fate inside the cellular compartment: a microscopic overview,” Langmuir, vol. 21, pp. 10644–10654, 2005. View at Google Scholar
  117. Y. Pan, S. Neuss, A. Leifert et al., “Size-dependent cytotoxicity of gold nanoparticles,” Small, vol. 3, pp. 1941–1949, 2007. View at Google Scholar
  118. X.-D. Zhang, H.-Y. Wu , D. Wu et al., “Toxicologic effects of gold nanoparticles in vivo by different administration routes,” International journal of nanomedicine, vol. 5, pp. 771–781, 2010. View at Google Scholar